Insight

Akhil Santhosh: FOWARC trial questions the role of RT in rectal cancer

shutterstock.com

Dec 16, 2024, 13:09

Akhil Santhosh: FOWARC trial questions the role of RT in rectal cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute and Post DM senior resident at AIIMS, New Delhi, posted the following on X:

“The 10-year results of FOWARC published in JCO ASCO today.

No difference in DFS, LR, and OS between 5FU-RT, FOLFOX-RT, and FOLFOX alone for LA rectal cancer
Second study after PROSPECT questioning the role of RT
More LAR syndrome and persistent ostomy in CRT compared to chemo alone.”

5FU-RT Akhil Santhosh cancer care clinical trials FOLFOX-RT FOWARC trial JCO ASCO LAR syndrome local recurrence OncoDaily Oncology oncology research persistent ostomy PROSPECT study radiation therapy rectal cancer

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage